IV thrombolysis in very severe and severe ischemic stroke-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IV thrombolysis in very severe and severe ischemic stroke

Published:2015-11-06 Issue:24 Volume:85 Page:2098-2106
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Mazya Michael V.,Lees Kennedy R.,Collas David,Rand Viiu-Marika,Mikulik Robert,Toni Danilo,Wahlgren Nils,Ahmed Niaz

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Reference21 articles.

1. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

2. Comparison of Outcomes Following Thrombolytic Therapy Among Patients With Prior Stroke and Diabetes in the Virtual International Stroke Trials Archive (VISTA)

3. Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke

4. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral microbleeds in acute ischemic stroke after intravenous thrombolysis and their impact on short term outcome of stroke;International Journal of Neuroscience;2024-08-23

2. Anticoagulation Therapy After Reperfusion Treatment for Non-Valvular Atrial Fibrillation-Related Acute Ischemic Stroke—A Multicenter Retrospective Study;2024-03-22

3. Risk factors for the outcome after thrombolysis in acute ischemic stroke – the prominent role of kidney dysfunction: A retrospective cohort observational study;Medicine;2023-10-27

4. Triglyceride-glucose index predicts death in patients with stroke younger than 65;Frontiers in Neurology;2023-08-03

5. Effect of Alteplase on Ischemic Stroke Mortality Is Dependent on Stroke Severity;Annals of Neurology;2023-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3